Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT03946800 Completed - Cancer Clinical Trials

A Study of MEDI1191 in Sequential and Concurrent Combination With Durvalumab in Subjects With Advanced Solid Tumors

Start date: May 8, 2019
Phase: Phase 1
Study type: Interventional

To evaluate MEDI1191 administered intratumorally in sequential and concurrent combination with intravenous durvalumab in patients with solid tumors.

NCT ID: NCT03945734 Completed - Cancer Clinical Trials

Expressive Helping for Chinese-Speaking Cancer Patients and Survivors

Start date: May 20, 2019
Phase: N/A
Study type: Interventional

This study examines the feasibility, cultural-sensitivity, and health effects of the expressive helping intervention by conducting a single-arm trial with Chinese-speaking cancer patients and survivors.

NCT ID: NCT03942614 Completed - Cancer Clinical Trials

Nordic Pole Walking for Individuals With Cancer

Start date: December 16, 2015
Phase: N/A
Study type: Interventional

Individuals diagnosed with cancer tend to be inactive and have symptom burdens that impact quality of life. A community-based Nordic Pole Walking (NPW) program may help. The primary objective of this study was to see if it was feasible to do to a larger trial. The secondary objective was to determine the effects of NPW on physical function and health-related quality of life (HRQoL). NPW or no NPW was randomly assigned to adults with non-small cell lung, prostate, colorectal, and endometrial. Eight people were enrolled in the study with 4 in the NPW group (1 dropped out) and 4 in the no NPW group.

NCT ID: NCT03941964 Completed - Cancer Clinical Trials

A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy

Start date: August 15, 2019
Phase: Phase 3
Study type: Interventional

A study evaluating the effectiveness and safety of venetoclax, in combination with azacitidine or decitabine, in an outpatient setting for treatment-naïve participants with AML who are ineligible for intensive chemotherapy.

NCT ID: NCT03940768 Completed - Cancer Clinical Trials

The Use of Lactobacillus Plantarum 299v in Treatment of Cancer Patients Who Received Home Enteral Nutrition

Start date: May 10, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to assess the impact of Lactobacillus plantarum 299v on nutritional status, tolerance of enteral diet and the quality of life. Administration of this probiotic may potentially improve nutritional status and tolerance of enteral diet. It also may provide positive effect on quality of life.

NCT ID: NCT03937934 Completed - Obesity Clinical Trials

Study Title: Food Rx

Start date: May 20, 2019
Phase: N/A
Study type: Interventional

Researchers are trying to determine if subjects with lack of access to healthy food and a long term health problem, are helped by a weekly box of healthy groceries and nutrition education.

NCT ID: NCT03936400 Completed - Cancer Clinical Trials

Development of Therapeutic Conversations With Females Diagnosed With Cancer and Their Partners

Start date: April 15, 2017
Phase: N/A
Study type: Interventional

The main purpose of the doctoral study is to better understand the experience of cancer diagnosis and treatment in how it effects sexuality and intimacy of the female cancer patient and her partner.

NCT ID: NCT03923296 Completed - Cancer Clinical Trials

PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients to Optimize Delivery of Systemic Therapy.

Start date: May 20, 2019
Phase:
Study type: Observational

Iterative co-design study where patients receiving systemic cancer therapy, carers and healthcare professionals involved in delivering cancer therapy, work with Entia to design a home based blood monitoring service. The iterative process means that at each stage of the development process, Entia will be building on what is learnt in the previous stage.

NCT ID: NCT03915288 Completed - Cancer Clinical Trials

MODERATE CONTINUOUS TRAINING VERSUS HIIT IN CANCER STADIUM II.

Start date: November 2015
Phase: N/A
Study type: Interventional

Introduction: Exercise programs focused on moderate intensity continuous training (MICT) and HIIT (High Intensity Interval Training) are shown as an effective treatment to mitigate the effects of cancer. Objective: To determine and compare the effects of MICT vs. HIIT on the cardiometabolic and psychosocial variables of the cancer patient. Methods and materials: Randomized controlled trial of 3 years and 4 months in participants with stage II cancer divided into 3 groups (MICT, HIIT and control group). Risk factors, blood samples for glycemia and lipid profile were identified. In addition, 6-minute walk, stress test for maximum heart rate (HRM), anthropometry, quality of life, fatigue, sarcopenia, depression, anxiety, clinical and hemodynamic parameters. All tests were done before and after 36 training sessions of 70 minutes, 3 times a week.

NCT ID: NCT03910296 Completed - Cancer Clinical Trials

Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain

Start date: February 20, 2019
Phase:
Study type: Observational

The purpose of this research study is to develop a psychological treatment for patients with cancer, focused on the psychological symptoms they experience during opioid therapy.